Stocks and Investing
Stocks and Investing
Wed, November 8, 2023
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Tue, November 7, 2023
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Jeffrey Zekauskas Maintained (CC) at Hold with Decreased Target to $26 on, Nov 7th, 2023
Jeffrey Zekauskas of JP Morgan, Maintained "The Chemours Company" (CC) at Hold with Decreased Target from $38 to $26 on, Nov 7th, 2023.
Jeffrey has made no other calls on CC in the last 4 months.
There are 5 other peers that have a rating on CC. Out of the 5 peers that are also analyzing CC, 4 agree with Jeffrey's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Duffy Fischer of "Goldman Sachs" Maintained at Hold with Decreased Target to $30 on, Tuesday, October 31st, 2023
- Michael Leithead of "Barclays" Maintained at Hold with Decreased Target to $28 on, Monday, October 30th, 2023
- Vincent Andrews of "Morgan Stanley" Maintained at Hold with Decreased Target to $28 on, Monday, October 30th, 2023
- Arun Viswanathan of "RBC Capital" Maintained at Hold with Decreased Target to $28 on, Monday, October 30th, 2023
This is the rating of the analyst that currently disagrees with Jeffrey
- John McNulty of "BMO Capital" Maintained at Buy with Decreased Target to $39 on, Monday, October 30th, 2023
Contributing Sources